BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9059936)

  • 1. The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantation.
    van Emmerik NE; Loonen EH; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
    J Heart Lung Transplant; 1997 Feb; 16(2):240-9. PubMed ID: 9059936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection.
    Vaessen LM; Baan CC; Ouwehand AJ; Balk AH; Jutte NH; Mochtar B; Claas FH; Weimar W
    Transplantation; 1994 Apr; 57(7):1051-9. PubMed ID: 8165702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease.
    van Besouw NM; Loonen EH; Vaessen LM; Balk AH; Claas FH; Weimar W
    Clin Exp Immunol; 1998 Mar; 111(3):548-54. PubMed ID: 9528897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?
    Jutte NH; Knoop CJ; Heijse P; Balk AH; Mochtar B; Claas FH; Weimar W
    J Heart Lung Transplant; 1997 Feb; 16(2):209-15. PubMed ID: 9059932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection.
    van Emmerik NE; Vaessen LM; Balk AH; Bos E; Claas FH; Weimar W
    Transplantation; 1996 Aug; 62(4):529-36. PubMed ID: 8781621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human heart-infiltrating cells after transplantation. VI. Differences in the cytokines produced by individual CD4+ cloned T-cell lines with apparently identical antiidiotype-like reactivity.
    Sell KW; Wang YC; Kanter K; Rodey GE; Mayne A; Ansari AA
    J Heart Lung Transplant; 1992; 11(3 Pt 1):511-21. PubMed ID: 1351745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation.
    Oei FBS ; Welters MJ; Vaessen LM; Stegmann AP; Bogers AJ; Weimar W
    J Heart Valve Dis; 2000 Nov; 9(6):761-8. PubMed ID: 11128781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograft.
    van Emmerik NE; Vaessen LM; Knoop CJ; Daane CR; Balk AH; Mochtar B; Claas FH; Weimar W
    Transpl Immunol; 1998 Sep; 6(3):153-60. PubMed ID: 9848221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of graft-infiltrating lymphocytes correlates with cellular rejection in cardiac transplant patients.
    Frisman DM; Fallon JT; Hurwitz AA; Dec WG; Kurnick JT
    Hum Immunol; 1991 Dec; 32(4):241-5. PubMed ID: 1686025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human heart-infiltrating cells after transplantation. V. Suppression of donor-specific allogeneic responses by cloned T-cell lines isolated from heart biopsy specimens of patients after transplantation.
    Sell KW; Kanter K; Rodey GE; Wang YC; Ansari AA
    J Heart Lung Transplant; 1992; 11(3 Pt 1):500-10. PubMed ID: 1351744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
    Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.